TY  - JOUR
AU  - Rico-Sanchez, Laura
AU  - Garzon, Ingrid
AU  - Gonzalez-Andrades, Miguel
AU  - Ruiz-Garcia, Antonio
AU  - Punzano, Miriam
AU  - Lizana-Moreno, Antonio
AU  - Muñoz-Avila, Jose Ignacio
AU  - Sanchez-Quevedo, Maria Del Carmen
AU  - Martinez-Atienza, Juliana
AU  - Lopez-Navas, Luis
AU  - Sanchez-Pernaute, Rosario
AU  - Oruezabal, Roke Iñaki
AU  - Medialdea, Santiago
AU  - Gonzalez-Gallardo, Maria Del Carmen
AU  - Carmona, Gloria
AU  - Sanbonmatsu-Gamez, Sara
AU  - Perez, Matias
AU  - Jimenez, Pilar
AU  - Cuende, Natividad
AU  - Campos, Antonio
AU  - Alaminos, Miguel
PY  - 2019
DO  - 10.1002/term.2951
UR  - http://hdl.handle.net/10668/14357
T2  - Journal of tissue engineering and regenerative medicine
AB  - Blindness due to corneal diseases is a common pathology affecting up to 23 million individuals worldwide. The tissue-engineered anterior human cornea, which is currently being tested in a Phase I/II clinical trial to treat severe corneal trophic...
LA  - en
PB  - Wiley
KW  - Advanced therapy medicinal products (ATMPs)
KW  - Clinical translation
KW  - Cornea
KW  - Preclinical research
KW  - Regulatory issues
KW  - Tissue engineering
KW  - Tissue-engineered anterior human cornea (TEAHC)
KW  - Animals
KW  - Biocompatible materials
KW  - Corneal diseases
KW  - Epithelium, corneal
KW  - Humans
KW  - Rabbits
KW  - Tissue engineering
TI  - Successful development and clinical translation of a novel anterior lamellar artificial cornea.
TY  - research article
VL  - 13
ER  -